GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Share Capital History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Share Capital | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr |
What is the latest Share Capital ratio of GLAND PHARMA ?
| Year | Share Capital |
|---|---|
| Mar2025 | ₹16 Cr |
| Mar2024 | ₹16 Cr |
| Mar2023 | ₹16 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹16 Cr |
How is Share Capital of GLAND PHARMA Trending?
| Years | Share Capital | % Change | |
|---|---|---|---|
| Mar2025 | ₹16 Cr | 0.03 | |
| Mar2024 | ₹16 Cr | 0.01 | |
| Mar2023 | ₹16 Cr | 0.24 | |
| Mar2022 | ₹16 Cr | 0.43 | |
| Mar2021 | ₹16 Cr | - | |
Compare Share Capital of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹35,583.6 Cr | -2.8% | 6.3% | 32.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,121.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,396.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,730.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,241.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,126.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -2.8% |
6.3% |
32.5% |
| SENSEX | -0.9% |
-3.6% |
-8.6% |
You may also like the below Video Courses